- Home
- PLSE vs DCOM Comparison
PLSE vs DCOM Comparison
Compare PLSE & DCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- DCOM
- Stock Information
- Founded
- PLSE 2014
- DCOM 1864
- Country
- PLSE United States
- DCOM United States
- Employees
- PLSE 75
- DCOM N/A
- Industry
- PLSE Medical/Dental Instruments
- DCOM Major Banks
- Sector
- PLSE Health Care
- DCOM Finance
- Exchange
- PLSE Nasdaq
- DCOM Nasdaq
- Market Cap
- PLSE 1.3B
- DCOM 1.2B
- IPO Year
- PLSE 2016
- DCOM 1996
- Fundamental
- Price
- PLSE $19.87
- DCOM $30.35
- Analyst Decision
- PLSE Buy
- DCOM Buy
- Analyst Count
- PLSE 1
- DCOM 2
- Target Price
- PLSE $22.00
- DCOM $36.75
- AVG Volume (30 Days)
- PLSE 254.2K
- DCOM 192.7K
- Earning Date
- PLSE 10-29-2025
- DCOM 10-24-2025
- Dividend Yield
- PLSE N/A
- DCOM 3.29%
- EPS Growth
- PLSE N/A
- DCOM N/A
- EPS
- PLSE N/A
- DCOM 0.87
- Revenue
- PLSE N/A
- DCOM $314,165,000.00
- Revenue This Year
- PLSE N/A
- DCOM $49.66
- Revenue Next Year
- PLSE $700.00
- DCOM $16.29
- P/E Ratio
- PLSE N/A
- DCOM $34.79
- Revenue Growth
- PLSE N/A
- DCOM N/A
- 52 Week Low
- PLSE $13.77
- DCOM $23.25
- 52 Week High
- PLSE $25.00
- DCOM $37.60
- Technical
- Relative Strength Index (RSI)
- PLSE 70.79
- DCOM 55.11
- Support Level
- PLSE $17.10
- DCOM $29.35
- Resistance Level
- PLSE $19.94
- DCOM $31.23
- Average True Range (ATR)
- PLSE 0.83
- DCOM 0.69
- MACD
- PLSE 0.20
- DCOM -0.07
- Stochastic Oscillator
- PLSE 78.67
- DCOM 49.62
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.